U.S. market Open. Closes in 1 hour 30 minutes

KDNY | Chinook Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue6.13M51.62M827.00K17.26M15.09M
Cost of Revenue1.72M1.69M422.00K554.00K584.00K
Gross Profit4.41M49.94M405.00K16.70M14.50M
Operating Expenses179.22M130.57M55.54M19.97M115.86M
Selling, General & Admin36.29M31.90M19.07M2.96M36.03M
Research & Development141.21M96.99M36.05M17.01M75.84M
Other Operating Expenses1.72M1.69M422.00K299.00K3.99M
Operating Income-185.08M-99.04M-56.23M-19.97M-101.36M
Other Expenses / Income4.81M-170.00K-27.40M-26.55M5.22M
Before Tax Income-180.27M-99.21M-83.62M-46.52M-96.14M
Income Tax Expenses4.34M2.09M-2.00M332.00K783.00K
Net Income-184.62M-101.30M-81.62M-46.85M-95.36M
Interest Expenses7.18MN/A15.00K33.00KN/A
Basic Shares Outstanding64.37M45.61M13.17M42.16M78.81B
Diluted Shares Outstanding64.37M45.61M13.17M42.16M78.81B
EBITDA-164.20M-57.17M-53.98M-19.45M-101.36M
EBITDA Margin-2,679.44%-110.74%-6,527.45%-112.68%-671.84%
EBIT-173.10M-99.21M-83.61M-46.49M-94.57M
EBIT Margin-2,824.67%-192.17%-10,110.04%-269.36%-626.86%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙